Small molecule inhibitor for Heart Failure via improving cardiac remodeling and fibrosis
Cardiovascular
Chronic heart failure
Best in class Novel pan-KRAS degrader
Oncology/Cancer
Solid tumor
A highly potent, orally bioavailable, tri-complex RASmulti(ON) inhibitor
Oncology/Cancer
Solid tumor ( NSCLC, Pancreatic Ductal Adenocarcinoma )